Anne Wojcicki is co-founder and CEO of 23andMe. She co-founded 23andMe with a goal to help people access, understand, and benefit from the sequencing of the human genome and fundamentally change health care in the process. Prior to founding 23andMe, Wojcicki spent a decade on Wall Street investing in health care. Frustrated by a system built around monetizing illness instead of incentivizing prevention, she wanted to build a business that helps people prevent illness rather than profit from it. Wojcicki focused on empowering people with direct access to genetic information so that they could use their data to make decisions that could lower their risks for disease. Under her leadership, 23andMe has transformed how research discoveries are made and revolutionized the development of treatments for disease by leveraging human genetics.